This move is archived. Current quotes and coverage live on the stock page.
Follow VVTM
VVT Med Inc. is experiencing a significant rise in its stock price, thanks to recent developments in its operations.
VVT Med Inc. (VVTM.V) saw its stock increase by 4.35% today, closing at CA$0.24. This uptick comes alongside some promising news about the company’s medical innovations and financial strategies.
Advertisement
VVT Med Inc.
VVTM.V
VVTM.V
VVT Med Inc.
WealthAwesomeMarket cap
$14.52M
52W high
$0.45
52W low
$0.15
1W change
+0.00%
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on VVTM's historical volatility
30-Day Vol
123.7%
Annualized
90-Day Vol
188.5%
Annualized
Trend (90d)
+44.3%
Annualized drift
90d Mean
C$0.23
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.21 | C$0.14 – C$0.32 |
| 60 trading days | C$0.22 | C$0.12 – C$0.41 |
| 90 trading days | C$0.23 | C$0.11 – C$0.49 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Keep an eye on VVT Med Inc. Recent advancements in medical technology and strategic financial decisions could indicate growth potential.
VVT Med Inc. stock rises 4.35% today
The market cap of VVT Med Inc. is around CA$16.1 million, highlighting its role in the medical technology sector.
Bull case
The successful treatment of patients in Italy using the ScleroSafe™ System may boost VVT Med Inc.'s reputation and appeal in the medical field. This could lead to increased sales and new partnerships.
Bear case
Despite today’s gains, VVT Med Inc. faces some hurdles. A management cease trade order and overdue financial statements may raise concerns for investors.
Recent Developments
Advertisement
VVT Med Inc. recently announced that it successfully treated the first patients in Italy with its ScleroSafe™ System, a minimally invasive solution for venous disease. This achievement could enhance the company’s credibility and attract more interest from investors and healthcare providers.
Financial Moves
The company has also launched a non-brokered private placement offering of up to 12 million units at CA$0.25 each, aiming to raise up to CA$3 million. These financial moves could strengthen VVT Med Inc.'s operational capabilities and support its growth trajectory.
Market Sentiment
While the stock is up today, investors should stay cautious due to the management cease trade order linked to delays in filing financial statements. This situation might impact investor confidence and market performance in the future.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
